Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prograf vs Neoral in Kidney Transplant Recipients With Type 2 Diabetes
NCT00296296Phase 4Completed
- Sponsor
- Stanford University
- Start
- Jun 2005
- Primary completion
- Oct 2014
- Modality
- Peptides, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus, cyclosporine in kidney transplant rejection, sponsored by Stanford University. Started Jun 2005; status: completed.
02
Drugs
tacrolimuscyclosporine
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00296296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296296.